RxDoctor Payments Data

Thomas Jacob, MD

Surgery of the Hand · Media, PANPI 1255347977

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 32.5% of the total. Reporting peaked in 2024 at $208 and has fallen 81.0% since, to $39 in 2025. That places this record below the midpoint for surgery of the hand clinicians in PA, where the typical reported total is $3,182.

$777in general payments, 2019–2025

Across 35 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$253
  • Integra Lifesciences Corporation$121
  • Lifenet Health$116
  • Urgo Medical North America, LLC$39
  • Polynovo North America LLC$33
  • Kerecis Limited$31
  • plus $184 from 9 others

What the payments were for

  • Food & beverage$777100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$777 in reported general payments places this provider in the 25th percentile of 20 surgery of the hand providers in Pennsylvania.

See all surgery of the hand providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$81,428
Medicare patients
212
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin48$353
Oxycodone Hcl52$325
Cephalexin25$160

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Media

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →